De novo immunosuppression with mammalian target of rapamycin inhibitors and posttransplantation malignancy in focus

Transplant Proc. 2009 Jul-Aug;41(6 Suppl):S42-4. doi: 10.1016/j.transproceed.2009.06.158. Epub 2009 Jul 9.
No abstract available

MeSH terms

  • Calcineurin Inhibitors
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Kidney Transplantation / adverse effects*
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / pathology
  • Neoplasms / epidemiology*
  • Neoplasms / prevention & control
  • Postoperative Complications / epidemiology*
  • Postoperative Complications / prevention & control
  • Prognosis
  • Protein Kinases / physiology*
  • Randomized Controlled Trials as Topic
  • Risk Reduction Behavior
  • Sirolimus / therapeutic use*
  • TOR Serine-Threonine Kinases

Substances

  • Calcineurin Inhibitors
  • Immunosuppressive Agents
  • Protein Kinases
  • MTOR protein, human
  • TOR Serine-Threonine Kinases
  • Sirolimus